We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Wiser Choices in Acute Myocardial Infarction

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00888537
Recruitment Status : Completed
First Posted : April 27, 2009
Last Update Posted : March 21, 2016
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
Patients who are hospitalized because of a heart attack are prescribed a number of medicines to help the heart heal. The investigators will examine different ways in which clinicians share information about those treatment options with patients and the impact that this can have on patients' choices and health.

Condition or disease Intervention/treatment
Acute Myocardial Infarction Other: AMI Choice Decision Aid Other: Usual Care

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 107 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Investigator)
Primary Purpose: Treatment
Official Title: Wiser Choices in Acute Myocardial Infarction
Study Start Date : March 2009
Primary Completion Date : June 2011
Study Completion Date : June 2011

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Heart Attack
U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Decision Aid
Patients in this arm will discuss medications to help the heart heal after a heart attack with the clinician and the help of the acute myocardial infarction (AMI) Choice Decision Aid.
Other: AMI Choice Decision Aid
The decision aid describes the risk of dying in the first six months following a heart attack without and with taking a bundle of medications to help the heart heal.
Active Comparator: Usual Care
Patients and clinicians in this arm will discuss medications to help the heart heal after a heart attack in their usual manner.
Other: Usual Care
Patients and clinicians in this arm will discuss medications to help the heart heal after a heart attack in their usual manner.


Outcome Measures

Primary Outcome Measures :
  1. Increases adherence to cardiac medications with proven benefits [ Time Frame: 6 months ]
  2. Reduces patients' decisional conflict (increase patient decisional quality) [ Time Frame: During hospital stay ]
  3. Decreases rehospitalization rates and death [ Time Frame: 5 weeks and 6 months ]
  4. Increase patient knowledge of medication to help the heart heal [ Time Frame: During hospital stay ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 90 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Between the ages of 18 and 90
  • Hospitalized at Saint Marys Hospital
  • A primary diagnosis of AMI,
  • Have heart rate, blood pressure, troponin and creatinine measurements,
  • There is an intention to offer treatment medications
  • Are able and willing to provide informed consent

Exclusion Criteria:

  • Have not had a myocardial infarction
  • Have significant cognitive, visual impairment,
  • Non-English speaker
  • Have a Do Not Intubate/Do Not Resuscitate (DNI/DNR) status
  • Will be discharged to a nursing home
  • AMI is not the presumptive diagnosis
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00888537


Locations
United States, Minnesota
Saint Marys Hospital, Mayo Clinic
Rochester, Minnesota, United States, 55905
Sponsors and Collaborators
Mayo Clinic
Investigators
Principal Investigator: Henry Ting, MD Mayo Clinic
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Nilay D. Shah, MD, Mayo Clinic
ClinicalTrials.gov Identifier: NCT00888537     History of Changes
Other Study ID Numbers: 09-000748
First Posted: April 27, 2009    Key Record Dates
Last Update Posted: March 21, 2016
Last Verified: March 2016

Keywords provided by Nilay D. Shah, Mayo Clinic:
Decision aid
Heart attack
myocardial infarction

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases